11.12.2012 Views

continued from part 1 - Controller General of Patents, Designs, and ...

continued from part 1 - Controller General of Patents, Designs, and ...

continued from part 1 - Controller General of Patents, Designs, and ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(12) PATENT APPLICATION PUBLICATION (21) Application No.6563/DELNP/2008 A<br />

(19) INDIA<br />

(22) Date <strong>of</strong> filing <strong>of</strong> Application :28/07/2008 (43) Publication Date : 24/10/2008<br />

(54) Title <strong>of</strong> the invention : MUCOSAL IMMUNOGENIC SUBSTANCES COMPRISING A POLYINOSINIC ACID-<br />

POLYCYTIDILIC ACID BASED ADJUVANT<br />

(51) International classification :A61P 31/00 (71)Name <strong>of</strong> Applicant :<br />

(31) Priority Document No :11/331,839<br />

1)NEWBIOMED PIKA PTE LTD<br />

(32) Priority Date :13/01/2006<br />

Address <strong>of</strong> Applicant :20 MAXWELL ROAD #08-11<br />

(33) Name <strong>of</strong> priority country :U.S.A.<br />

MAXWELL HOUSE SINGAPORE 069113 SINGAPORE<br />

(86) International Application No :PCT/SG2006/000177 Singapore<br />

Filing Date<br />

:27/06/2006 (72)Name <strong>of</strong> Inventor :<br />

(87) International Publication No : WO2007/081288 1)HAIXIANG LIN<br />

(61) Patent <strong>of</strong> Addition to Application<br />

Number<br />

Filing Date<br />

:NA<br />

:NA<br />

2)VICTOR LIE TAO LI<br />

(62) Divisional to Application Number :NA<br />

Filing Date<br />

:NA<br />

(57) Abstract :<br />

The present invention provides a polynucleotide adjuvant (PICKCa) composition <strong>and</strong> methods <strong>of</strong> use in eliciting an immune response,<br />

in <strong>part</strong>icular a mucosal immune response. The polynucleotide adjuvant comprises <strong>of</strong> a polyriboinosinic-polyribocytidylic acid (PIC),<br />

at least one antibiotic <strong>and</strong> at least one positive ion. The present invention also provides an immunogenic composition comprising the<br />

polynucleotide adjuvant composition together with other immunogenic compositions such as an antigen (e.g., as in a vaccine). The<br />

present invention further contemplates methods <strong>of</strong> use <strong>of</strong> such adjuvant compositions, <strong>part</strong>icularly in eliciting an immune response, in<br />

<strong>part</strong>icular a mucosal immune response to an antigenic compound.<br />

No. <strong>of</strong> Pages : 85 No. <strong>of</strong> Claims : 19<br />

The Patent Office Journal 24/10/2008 26103

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!